Denali Therapeutics: Shall Not Be Deemed To Be “filed” For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the “exchange Act”), Or Otherwise Subject To The Liabilities Of That Section, Nor Shall It Be Deemed Incorporated By Reference Into Any Filing Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Except As Shall Be Expressly Set Forth By Specific Reference In Such A Filing

Show full article

This functionality is available for registred users only

• Full name
  Denali Therapeutics Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***